Publicacións en colaboración con investigadores/as de French Institute of Health and Medical Research (3)

2018

  1. Translating molecular advances in Down syndrome and Fragile X syndrome into therapies

    European Neuropsychopharmacology, Vol. 28, Núm. 6, pp. 675-690

2017

  1. CB1 Cannabinoid Receptors Mediate Cognitive Deficits and Structural Plasticity Changes During Nicotine Withdrawal

    Biological Psychiatry, Vol. 81, Núm. 7, pp. 625-634

2015

  1. Cognitive impairment induced by delta9- tetrahydrocannabinol occurs through heteromers between cannabinoid CB1 and serotonin 5-HT2A receptors

    PLoS Biology, Vol. 13, Núm. 7